FDA-cleared profile

BoneMRI

MRIguidance B.V · MRI · FDA-cleared (510(k))

MRI-processing software that creates an added bone-contrast image series for review beside the original scan.

Clinical role
Standalone MRI image-processing server that creates an adjunctive bone-visualization series while the original DICOM study remains available for standard interpretation.
Images and patients
MRI · Spine
Key limitation
BoneMRI images co-exist with the original MRI images and are not intended to replace CT images in general.

Overview status: Source-reviewed overview

Report a correction

Evaluation pilot

Before you shortlist

Exact FDA record: K233030 · Agent source review · . This is not clinician review or local acceptance.

Within this record's scope

  • Consider for an added bone-visualization series from a dedicated 3D MRI protocol of the pelvis or spine in patients aged 12 or older.

Limits to check

  • It is not a general CT replacement and is not for diagnosing or monitoring primary or metastatic tumors.

Questions for the vendor and your team

  1. Which anatomy, protocol and release are licensed, and which exact submission supports the proposed use?
  2. Can the site acquire the required protocol and show the added series beside the original MRI for professional interpretation?

These questions are prompts for evaluation, not claims that licensing, compatibility, performance or price has been confirmed.

Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Image processing · source-reviewed 2026-11-12

Agent source review of original FDA labeling; not clinician sign-off or local workflow qualification.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?It creates MRI-based images that make bone stand out more clearly from surrounding soft tissue.
  • Which scans and patients is it intended for?It is for people aged 12 and older who have dedicated 3D MRI of pelvic or spinal bone structures.
  • Who uses it?Imaging experts, such as radiologists or orthopedic surgeons, use the added image series during review.
  • What does the software produce, and what must the clinician do?It returns a standard image-file (DICOM) BoneMRI series that co-exists with the original MRI images. The clinician reads it in regular DICOM-compatible viewing software.
  • What is its most important limitation?It is not intended to replace CT images in general and is not for diagnosing or monitoring primary or metastatic tumors.

Clinical takeaway. BoneMRI is an added MRI image-processing series for bone visualization. It is reviewed alongside the original MRI, not as a general CT substitute.

Evidence takeaway. The FDA submission describes quantitative validation against paired CT in pelvic and spine patients, with stated acceptance bounds. This is a technical validation measure, not a reported patient-outcome measure.

Additional limitations
  • It is not intended for diagnosis or monitoring of primary or metastatic tumors.

Evidence context: questions, not a score

Agent transcription of regulatory evidence context, not independent validation, clinical acceptance or a product recommendation. Separate studies and outcomes are not a leaderboard.

K233030 · agent source review 2026-11-12 · exact submission

Existing study anchor: K233030 BoneMRI quantitative voxel-by-voxel validation. Tested version label: BoneMRI release reviewed in FDA submission K233030.

What was tested?

Quantitative agreement of BoneMRI bone morphology, radiodensity and radiodensity contrast with paired CT.

Source section: 510(k) summary, section 9: Performance Data and Performance Validation

On which cases and versions?

76 patients contributed pelvic-region data and 117 contributed spine-region data. Test images were unseen during development; the source describes different sites, departments or studies from training. Cohorts are not assumed to be disjoint.

Source section: 510(k) summary, section 9: Performance Data and Performance Validation

What changed?

The regulatory package reports quantitative morphology/radiodensity endpoints against CT. This is image-reconstruction validation, not evidence of cancer detection or improved treatment outcomes.

Source section: 510(k) summary, section 9: Performance Data and Performance Validation

What does this not establish?

Agreement with CT on these measures does not establish a general CT replacement, tumor diagnosis/monitoring or treatment-planning authorization. Manufacturer validation is not independent-investigator validation.

Source section: 510(k) summary, section 9: Performance Data and Performance Validation

Study design, population and missing context
evidence Role
Retrospective technical validation of paired BoneMRI and CT images, not a disease-detection or treatment-outcome trial.

technical validation · 510(k) summary, section 9: Performance Data and Performance Validation

design
Quantitative voxel-by-voxel validation using paired images from previously conducted clinical investigations; test data were unseen during development.

technical validation · 510(k) summary, section 9: Performance Data and Performance Validation

setting
Test data acquired at different medical sites, departments or studies than training; exact site count not stated in the reviewed passage.

technical validation · 510(k) summary, section 9: Performance Data and Performance Validation

training Population
Not established: The reviewed regulatory summary does not establish this field for this study context.
evaluation Population
76 patients with pelvic-region data and 117 with spine-region data. Cohort counts are retained separately; unique-patient overlap across cohorts is not established here.

technical validation · 510(k) summary, section 9: Performance Data and Performance Validation

reference Standard
Paired CT of the same patient in the same anatomical region for morphology and radiodensity comparisons.

technical validation · 510(k) summary, section 9: Performance Data and Performance Validation

comparator
BoneMRI outputs versus co-registered CT; endpoints describe morphology, radiodensity and radiodensity contrast.

technical validation · 510(k) summary, section 9: Performance Data and Performance Validation

sites
Not established: The reviewed regulatory summary does not establish this field for this study context.
scanner Protocol
Input from a specified gradient-echo MRI sequence; paired CT acquired using standard-of-care bone imaging protocols.

technical validation · 510(k) summary, section 9: Performance Data and Performance Validation

sample Composition
Pelvic cohort n=76 and spine cohort n=117, retained as distinct denominators rather than asserting 193 unique patients.

technical validation · 510(k) summary, section 9: Performance Data and Performance Validation

sponsor Involvement
Validation conducted by MRIguidance. Unseen test data do not establish independent investigators.

regulatory summary · 510(k) summary, section 9: Performance Data and Performance Validation

Public-label constraints

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Exact FDA submission K233030 · agent source review 2026-11-12 · BoneMRI release reviewed in FDA submission K233030

Label age limits

Patients 12 years and older. No numerical upper bound transcribed.

Documented care setting

Not established: No explicit constraint transcribed from the reviewed labeling sections. Unknown does not mean unrestricted.

Modality and protocol

MRI image enhancement; dedicated 3D gradient-echo MRI scan protocol.

Labeled anatomy

Pelvic bony sacrum, hip bones and femoral heads; spine cervical, thoracic, lumbar and S1 vertebrae.

Acquisition constraints

Input 3D gradient-echo MRI scans acquired with a dedicated MRI scan protocol.

Exclusions and human review

Not for diagnosis or monitoring of primary or metastatic tumors. BoneMRI images are not intended to replace CT images in general.

Purpose
MRI-based BoneMRI image enhancement for visualizing pelvic and cervical, thoracic, lumbar and S1 spinal bone structures with CT-like radiodensity contrast; not for tumor diagnosis or monitoring and not a CT replacement.
  • Exact FDA submission
  • Checked 2026-09-07
Workflow role
Standalone MRI image-processing server that creates an adjunctive bone-visualization series while the original DICOM study remains available for standard interpretation.
  • Exact FDA submission
  • Checked 2026-09-07
Required input
DICOM 3D gradient-echo MRI images acquired using a dedicated MRI protocol.
  • Exact FDA submission
  • Checked 2026-09-07
Output and clinician action
DICOM BoneMRI images for viewing in a regular DICOM-compatible viewer, with 3D bone morphology, tissue radiodensity and tissue-radiodensity contrast visualized alongside the original images.
  • Exact FDA submission
  • Checked 2026-09-07
Care setting
Physician-office and clinic or hospital MRI/PACS workflows; indicated for patients 12 years and older.
  • Exact FDA submission
  • Checked 2026-09-07
Intended users
Imaging experts such as radiologists or orthopedic surgeons.
  • Exact FDA submission
  • Checked 2026-09-07
Limitations
Not for diagnosis or monitoring of primary or metastatic tumors; BoneMRI images are not intended to replace CT images in general.
  • Exact FDA submission
  • Checked 2026-11-12
Evidence summary
K233030 BoneMRI was validated with paired BoneMRI and CT images from 76 pelvic and 117 spine patients. The FDA summary reports bounds for morphology and radiodensity agreement, not exact aggregate point estimates.
  • Exact FDA submission
  • Checked 2026-09-07

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K233030 BoneMRI was validated with paired BoneMRI and CT images from 76 pelvic and 117 spine patients. The FDA summary reports bounds for morphology and radiodensity agreement, not exact aggregate point estimates.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K233030 BoneMRI quantitative voxel-by-voxel validation

  • DesignQuantitative validation using paired BoneMRI and CT images from previously conducted clinical investigations; test data were unseen during development.
  • Population76 patients with pelvic-region data and 117 patients with spine-region data.
  • Scopeexact submission
  • Tested versionBoneMRI release reviewed in FDA submission K233030
  • IndependenceIndependence not established

K233030

Validation was conducted by MRIguidance; independent-investigator status was not established. The FDA summary reports the pelvic (76) and spine (117) cohorts separately and states no combined unique-patient count.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
Service-level context: CMS Transmittal 13135 (April 2025) establishes HCPCS G0566 under the hospital outpatient payment system, effective 2025-04-01, for 3D image generation used in surgical planning and navigation for placing implants and devices in the spine and pelvis. MRIguidance states BoneMRI was assigned G0566 (APC 5721) from 2025-04-01 and that it is a hospital outpatient billing pathway. CMS names no product. The vendor statement is not version-specific, and this entry's cleared use is bone visualization. This is not a determination that this exact release is covered or paid. No payment amount, status indicator or APC was read.
  • Service-level, not product-specific
  • Checked 2026-10-26
IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM 3D gradient-echo MRI images acquired using a dedicated MRI protocol.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-07 · FDA 510(k) decision summary K233030: BoneMRI

  2. Routing

    Source context, not route validation: Communicates with a DICOM-compatible imaging archive such as PACS to receive MRI input and return BoneMRI images; regular DICOM viewing software displays the result, while receipt and delivery depend on other software systems.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-07 · FDA 510(k) decision summary K233030: BoneMRI

  3. AI processing

    Source context, not route validation: Server application on clinic or hospital networks, available fully on premises with specific GPU requirements or partly as a managed cloud service. The FDA summary states that on-premise PHI stays within the network and data sent to the managed cloud is de-identified before leaving it.

    Scope: Exact FDA submission. Deployment language is from the exact FDA submission; it does not establish a current contracted hosting or security configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-07 · FDA 510(k) decision summary K233030: BoneMRI

  4. Returned objects

    Source context, not route validation: DICOM BoneMRI images for viewing in a regular DICOM-compatible viewer, with 3D bone morphology, tissue radiodensity and tissue-radiodensity contrast visualized alongside the original images.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-07 · FDA 510(k) decision summary K233030: BoneMRI

  5. Viewer/worklist/report

    Unresolved route: DICOM BoneMRI images for viewing in a regular DICOM-compatible viewer, with 3D bone morphology, tissue radiodensity and tissue-radiodensity contrast visualized alongside the original images.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-07 · FDA 510(k) decision summary K233030: BoneMRI

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Server application on clinic or hospital networks, available fully on premises with specific GPU requirements or partly as a managed cloud service. The FDA summary states that on-premise PHI stays within the network and data sent to the managed cloud is de-identified before leaving it.
  • Exact FDA submission
  • Checked 2026-09-07

Deployment language is from the exact FDA submission; it does not establish a current contracted hosting or security configuration.

Integration
Communicates with a DICOM-compatible imaging archive such as PACS to receive MRI input and return BoneMRI images; regular DICOM viewing software displays the result, while receipt and delivery depend on other software systems.
  • Exact FDA submission
  • Checked 2026-09-07
Security
MRIguidance announced ISO 27001:2017 certification of its information security management system (certified 2022-04-22 by Brand Compliance), the certificate encompassing information security of the design and development, production, distribution, installation and servicing of the BoneMRI medical imaging processing software, both on premise and in cloud applications.
  • Product family
  • Checked 2026-10-27

Vendor statement; certificate not read. Scope explicitly names BoneMRI on-premise and cloud.

Exact deployment and DICOM/PACS path

The FDA summary describes on-premise or partly managed-cloud server deployment and DICOM archive/PACS input and return, with output viewed in regular DICOM software.

exact submission · checked 2026-09-07

Current BoneMRI family PACS and scanner workflow

MRIguidance's current BoneMRI family page describes 3D CT-like images reconstructed from MRI, forwarding reconstructed images to PACS, and compatibility with major MRI scanners.

product family · checked 2026-09-07

Current family material is buyer-relevant workflow context but does not establish feature parity or release identity for K233030.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K233030
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
MRI
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Anatomy
Spine
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07

The exact indication also includes the pelvic region; the controlled directory anatomy is normalized to Spine.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2024-03-01
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Documented product family

Related FDA records

These links identify a sourced product-family relationship. They do not transfer evidence, metrics, clearance scope, compatibility, pricing, or availability between submissions.

BoneMRI

Open the documented family

This is a documented BoneMRI product-family relationship. Each linked FDA submission remains a separate record with its own intended use, evidence, implementation facts, and limitations.

MRIguidance's official BoneMRI page is a current product-family source. The individual FDA decision materials identify the named submissions below. The family source does not establish feature parity, supersession, or current commercial availability for either submission.

Mapped FDA decisions, earliest first

Latest mapped does not mean latest sold or installed. Choose an exact FDA record before comparing.

  1. Related FDA recordBoneMRI v1.6 (K230197)

    BoneMRI v1.6 release reviewed in K230197

    FDA decision: 2023-02-22 · record reviewed 2026-09-07
  2. This FDA recordBoneMRI (K233030)

    BoneMRI release reviewed in K233030

    Latest mapped FDA decisionFDA decision: 2024-03-01 · record reviewed 2026-09-07
Latest FDA decision among these records
K233030 · 2024-03-01. This is the latest FDA decision date among the mapped records only. It is not a statement that K233030 supersedes K230197.
Latest documented release
No source reviewed for this mapping establishes a current commercial release chronology beyond the individual FDA records.
Current commercial availability
The reviewed materials do not establish current commercial availability or an installed version.

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-07Last searched
24Fields reviewed
13Source classes checked
18Screened PubMed leads
2Screened trial leads
0Unreviewed FDA recall leads

The stored PubMed and ClinicalTrials candidate metadata were screened in the exact stored order; this was metadata triage, not full-text paper or registry-record review, and no candidate was promoted. The stored recall query returned no records, so no event was promoted and no absence claim is made. The current discovery snapshot contains 18 PubMed and 2 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, literature index, trial registry, stored candidate metadata, stored recall candidates, payer policy, vendor documentation, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-07 - Exact FDA submission

    No public exact-submission price or procurement terms were reviewed.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-10-27 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

12 sources - 3 history items

Source ledger

  1. K233030 FDA decision source

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, purpose, modality, anatomy

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. BoneMRI model card (K233030)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, limitations, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. FDA 510(k) decision summary K233030: BoneMRI

    U.S. Food and Drug Administration - Published 2024-03-01 - Accessed 2026-09-07

    Scope: identity, clinicalUse, purpose, modality, anatomy, input, output, limitations, deployment, integration, evidenceSummary, evidenceStudies

  8. FDA 510(k) decision summary K230197: BoneMRI v1.6

    U.S. Food and Drug Administration - Published 2023-02-22 - Accessed 2026-09-07

    Scope: identity, clinicalUse, purpose, modality, anatomy, input, output, limitations, deployment, integration, evidenceSummary, evidenceStudies

  9. BoneMRI official product and workflow page

    MRIguidance B.V. - Accessed 2026-09-07

    Scope: product_family, clinical_use, output, PACS_integration, scanner_compatibility, implementationCapabilities

  10. CMS Transmittal 13135: April 2025 Update of the Hospital Outpatient Prospective Payment System

    Centers for Medicare & Medicaid Services - Accessed 2026-10-26

    Scope: reimbursement, payerPolicy

  11. MRIguidance news release: BoneMRI receives Medicare billing code

    MRIguidance - Published 2025-04-29 - Accessed 2026-10-26

    Scope: reimbursement

  12. MRIguidance: ISO 27001:2017 Certification Announcement

    MRIguidance - Published 2022-05-18 - Accessed 2026-10-27

    Scope: security

Research history

  1. K233030 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K230197

BoneMRI v1.6

MRIguidance B.V.

Authorized purpose: MRI-based BoneMRI v1.6 image enhancement for visualizing pelvic and L3-S1 lumbar bone structures with enhanced contrast; not for tumor diagnosis or monitoring and not a CT replacement.

Modality
MRI
Anatomy
Spine
Decision
2023-02-22
FDA-cleared K220497

CoLumbo

Smart Soft Healthcare AD

Authorized purpose: CoLumbo is an image post-processing and measurement software tool that provides quantitative spine measurements from previously-acquired DICOM lumbar spine Magnetic Resonance (MR) images for users' review, analysis, and interpretation. It provides the following functionality to assist users in visualizing, measuring and documenting out-of range measurements:- Feature segmentation;- Feature measurement;- Threshold-based labeling of out-of-range measurement; and- Export of measurement results to a written report for user's review, revise and approval. Columbo does not produce or recommend any type of medical diagnosis or treatment. Instead, it simply helps users to more easily identify and classify features in lumbar MR images and compile a report. The user is responsible forconfirming/modifying settings, reviewing and verifying the software-generated measurements, inspecting out-of-range measurements, and approving draft report content using their medical judgment and discretion. The device is intended to be used only by hospitals and other medical institutions. Only DICOM images of MRI acquired from lumbar spine exams of patients aged 18 and above are considered to be valid input. CoLumbo does not support DICOM images of patients that are pregnant, undergo MRI scan with contrast media, or have post-operational complications, scoliosis, tumors, infections, fractures.

Modality
MRI
Anatomy
Spine
Decision
2022-06-23
FDA-cleared K241329

SubtleSYNTH (1.x)

Subtle Medical, Inc.

Authorized purpose: SubtleSYNTH is a software medical device consisting of a machine-learning algorithm that synthesizes a SynthSTIR contrast image from T1-weighted and T2-weighted spine MR images.

Modality
MRI
Anatomy
Spine
Decision
2024-07-11

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history